Biodistribution processes as underestimated confounders in translational stroke research

Current Medicinal Chemistry

Volumn 14, Issue 30, 2007, Pages 3179-3184

  Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

ABC transporter; Focal cerebral ischemia; Pharmacology

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; [[3,4 DIHYDRO 7 MORPHOLINO 2,3 DIOXO 6 (TRIFLUOROMETHYL) 1(2H) QUINOXALINYL]METHYL]PHOSPHONIC ACID; ABC TRANSPORTER; APTIGANEL; CITICOLINE; CLOMETHIAZOLE; DISUFENTON SODIUM; FIBRINOLYTIC AGENT; GAVESTINEL; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LIFARIZINE; LUBELUZOLE; MULTIDRUG RESISTANCE PROTEIN 1; NIMODIPINE; SIPATRIGINE; TIRILAZAD; TISSUE PLASMINOGEN ACTIVATOR; ZOSUQUIDAR;

BLOOD BRAIN BARRIER; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FATALITY; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG TREATMENT FAILURE; FEVER; HUMAN; INFECTION; LEUKEMIA; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; PSYCHOSIS; REVIEW; SIDE EFFECT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ATP-BINDING CASSETTE TRANSPORTERS; BLOOD-BRAIN BARRIER; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; NEUROPROTECTIVE AGENTS; STROKE; TISSUE DISTRIBUTION;

EID: 37549022582     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986707782793817     Document Type: Review

References (74)

1. O'Collins, V.E.; Macleod, M.R.; Donnan, G.A.; Horky, L.L.; van der Worp, B.H.; Howells, D.W. Ann. Neurol., 2006, 59, 467.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med., 1995, 333, 1581.
3. Furlan, A.; Higashida, R.; Wechsler, L.; Gent, M.; Rowley, H.; Kase, C.; Pessin, M.; Ahuja, A.; Callahan, F.; Clark, W.M.; Silver, F.; Rivera, F. JAMA, 1999, 282, 2003.
4. Hermann, D.M.; Bassetti, C.L. Trends Pharmacol. Sci., 2007, 28, 128.
5. Stroke Therapy Academic Industry Roundtable. Stroke, 1999, 30, 2752.
6. Stroke Therapy Academic Industry Roundtable. Stroke, 2001, 32, 1598.
7. Stroke Therapy Academic Industry Roundtable. Stroke, 2003, 34, 1539.
8. Stroke Therapy Academic Industry Roundtable. Stroke, 2005, 36, 1808.
9. Lees, K.R.; Zivin, J.A.; Ashwood, T.; Davalos, A.; Davis, S.M.; Diener, H.C.; Grotta, J.; Lyden, P.; Shuaib, A.; Hardemark, H.G.; Wasiewski, W.W. Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. N. Engl. J. Med., 2006, 354, 588.
10. Shuaib, A.; Lees, K.R.; Lyden, P.; Grotta, J.; Davalos, A.; Davis, S.M.; Diener, H.C.; Ashwood, T.; Wasiewski, W.W.; Emeribe, U. Stroke-Acute Ischemic NXY Treatment (SAINT II) Trial Investigators. N. Engl. J. Med., 2007, 357, 562.
11. Fong, J.J.; Rhoney, D.H. J. Cereb. Blood Flow Metab., 2006, 40, 461.
12. Ginsberg, M.D. Stroke, 2007, 38, 1967.
13. Fisher, M. Cerebrovasc. Dis., 2006, 21 (Supp 2), 64.
14. Savitz, S.I. Exp. Neurol., 2007, 205, 20.
15. Saver, J.L. Stroke, 2007, 38, 1515.
16. Savitz, S.I.; Fisher, M. Ann. Neurol., 2007, 61, 396.
17. Hermann, D.M.; Bassetti, C.L. Ann. Neurol., 2007; [Epub ahead of print].
18. Begley, D.J. Pharmacol. Ther., 2004, 104, 29.
19. Kilic, E.; Kilic, Ü.; Hermann, D.M. CNS Drug Rev., 2005, 11, 369.
20. Abbott, N.J.; Rönnbäck, L.; Hansson, E. Nat. Rev. Neurosci., 2006, 7, 41.
21. Lum, H.; Malik, A.B. Can. J. Physiol. Pharmacol., 1996, 74, 787.
22. Wolburg, H.; Lippoldt, A. Vascul. Pharmacol., 2002, 38, 323.
23. Wang, Y.; Kilic, E.; Kilic, Ü.; Weber, B.; Bassetti, C.L.; Marti, H.H.; Hermann, D.M. Brain, 2005, 128, 52.
24. Kilic, E.; Kilic, Ü.; Wang, Y; Bassetti, C.L.; Marti, H.H.; Hermann, D.M. FASEB J., 2006, 20, 1185.
25. Huber, J.D.; Egleton, R.D.; Davis, T.P. Trends Neurosci., 2001, 24, 719.
26. Cipolla, M.J.; Crete, R.; Vitullo, L.; Rix, R.D. Front. Biosci., 2004, 9, 777.
27. Tsukamoto, T.; Nigam, S.K. J. Biol. Chem., 1997, 272, 16133.
28. Kondo, T.; Kinouchi, H.; Kawase, M.; Yoshimoto, T. Neurosci. Lett., 1996, 208, 101.
29. Yamagata, K.; Tagami, M.; Nara, Y.; Fujino, H.; Kubota, A.; Numano, F.; Kato, T.; Yamori, Y. Clin. Exp. Pharmacol. Physiol., 1997, 24, 686.
30. Latour, L.L.; Kang, D.W.; Ezzeddine, M.A.; Chalela, J.A.; Warach, S. Ann. Neurol., 2004, 56, 468.
31. Löscher, W.; Potschka, H. Nat. Rev. Neurosci., 2005, 6, 591.
32. Higgins, C.F.; Linton, K.J. Nat. Struct. Mol. Biol., 2004, 11, 918.
33. Hermann, D.M.; Kilic, E.; Spudich, A.; Krämer, S.D.; Wunderli-Allenspch, H.; Bassetti, C.L. Ann. Neurol., 2006, 60, 489.
34. Gottesman, M.M.; Fojo, T; Bates, S.E. Nat. Rev. Cancer, 2002, 2, 48.
35. Wartenberg, M.; Ling, F.C.; Muschen, M.; Klein, F.; Acker, H.; Gassmann, M.; Petrat, K.; Putz, V.; Hescheler, J.; Sauer, H. FASEB J., 2003, 17, 503.
36. Felix, R.A.; Barrand, M.A. J. Neurochem., 2002, 80, 64.
37. Zhu, H.J.; Liu, G.Q. Life Sci., 2004, 75, 1313.
38. Comerford, K.M.; Wallace, T.J.; Karhausen, J.; Louis, N.A.; Montalto, M.C.; Colgan, S.P. Cancer Res., 2002, 62, 3387.
39. Spudich, A.; Kilic, E.; Xing, H.; Kilic, Ü.; Rentsch, K.M.; Wunderli-Allenspach, H.; Bassetti, C.L.; Hermann, D.M. Nat. Neurosci., 2006, 9, 487.
40. Kemper, E.M.; van Zandbergen, A.E.; Cleypool, C.; Mos, H.A.; Boogerd, W.; Beijnen, J.H.; van Tellingen, O. Clin. Cancer Res., 2003, 9, 2849.
41. Abbott, N.J.; Khan, E.U.; Rollinson, C.M.; Reichel, A.; Janigro, D.; Dombrowski, S.M.; Dobbie, M.S.; Begley, D.J. Novartis Found. Symp., 2002, 243, 38.
42. Szakacs, G.; Paterson, J.K.; Ludwig, J.A.; Booth-Genthe, C.; Gottesman, M.M. Nat. Rev. Drug Discov., 2006, 5, 219.
43. Hagenbuch, B.; Meier, P.J. Pflugers Arch., 2004, 447, 653.
44. Kusuhara, H.; Sugiyama, Y. NeuroRx, 2005, 2, 73.
45. Murakami, S.; Nakashima, R.; Yamashita, E.; Matsumoto, T.; Yamaguchi, A. Nature, 2006, 443, 173.
46. Marzolini, C.; Paus, E.; Buclin, T.; Kim, R.B. Clin. Pharmacol. Ther., 2004, 75, 13.
47. Hoffmeyer, S.; Burk, O.; von Richter, O.; Arnold, H.P.; Brockmoller, J.; Johne, A.; Cascorbi, I.; Gerloff, T.; Roots, I.; Eichelbaum, M.; Brinkmann, U. Proc. Natl. Acad. Sci. USA, 2000, 97, 3473.
48. Fellay, J.; Marzolini, C.; Meaden, E.R.; Back, D.J.; Buclin, T.; Chave, J.P.; Decosterd, L.A.; Furrer, H.; Opravil, M.; Pantaleo, G.; Retelska, D.; Ruiz, L.; Schinkel, A.H.; Vernazza, P.; Eap, C.B.; Telenti, A. Lancet, 2002, 359, 30.
49. Siddiqui, A.; Kerb, R.; Weale, M.E.; Brinkmann, U.; Smith, A.; Goldstein, D.B.; Wood, N.W.; Sisodiya, S.M. N. Engl. J. Med., 2003, 348, 1442.
50. Nasi, M.; Borghi, V.; Pinti, M.; Bellodi, C.; Lugli, E.; Maffei, S.; Troiano, L.; Richeldi, L.; Mussini, C.; Esposito, R.; Cossarizza, A. AIDS, 2003, 17, 1696.
51. Thomas, H.; Coley, H.M. Cancer Control, 2003, 10, 159.
52. Agrawal, M.; Abraham, J.; Balis, F.M.; Edgerly, M.; Stein, W.D.; Bates, S.; Fojo, T.; Chen, C.C. Clin. Cancer Res., 2003, 9, 650.
53. Rubin, E.H.; de Alwis, D.P.; Pouliquen, I.; Green, L.; Marder, P.; Lin, Y.; Musanti, R.; Grospe, S.L.; Smith, S.L.; Toppmeyer, D.L.; Much, J.; Kane, M.; Chaudhary, A.; Jordan, C.; Burgess, M.; Slapak, C.A. Clin. Cancer Res., 2002, 8, 3710.
54. Gerrard, G.; Payne, E.; Baker, R.J.; Jones, D.T.; Potter, M.; Prentice, H.G.; Ethell, M.; McCullough, H.; Burgess, M.; Mehta, A.B.; Ganeshaguru, K. Haematologica, 2004, 89, 782.
55. Soontornmalai, A.; Vlaming, M.L.; Fritschy, J.M. Neuroscience, 2006, 138, 159.
56. Murakami, Y.; Takamatsu, H.; Noda, A.; Osoda, K.; Ichise, R.; Tatsumi, M.; Tabata, K.; Sawamoto, T.; Nishimura, S. J. Nucl. Med., 2004, 45, 1946.
57. Sharma, V.; Prior, J.L.; Belinsky, M.G.; Kruh, G.D.; Piwnica-Worms, D. J. Nucl. Med., 2005, 46, 354.
58. Lee, Y.J.; Maeda, J.; Kusuhara, H.; Okauchi, T.; Inaji, M.; Nagai, Y.; Obayashi, S.; Nakao, R.; Suzuki, K.; Sugiyama, Y.; Suhara, T. J. Pharmacol. Exp. Ther., 2006, 316, 647.
59. Davis, S.M.; Albers, G.W.; Diener, H.C.; Lees, K.R.; Norris, J. Lancet, 1997, 349, 32.
60. Albers, G.W.; Goldstein, L.B.; Hall, D.; Lesko, L.M. JAMA, 2001, 286, 2673.
61. Elting, J.W.; Sulter, G.A.; Kaste, M.; Lees, K.R.; Diener, H.C.; Hommel, M.; Versavel, M.; Teelken, A. W.; De Keyser, J. Stroke, 2002, 33, 2813.
62. Sacco, R.L.; DeRosa, J.T.; Haley, E.C. Jr.; Levin, B.; Ordronneau, P.; Phillips, S.J.; Rundek, T.; Snipes, R.G.; Thompson, J.L. JAMA, 2001, 285, 1719.
63. Wahlgren, N.G.; Ranasinha, K.W.; Rosolacci, T.; Franke, C.L.; van Erven, P.M.; Ashwood, T.; Claesson, L. Stroke, 1999, 30, 21.
64. Ahmed, N.; Nasman, P.; Wahlgren, N.G. Stroke, 2000, 31, 1250.
65. Infeld, B.; Davis, S.M.; Donnan, G.A.; Yasaka, M.; Lichtenstein, M.; Mitchell, P.J.; Fitt, G.J. Stroke, 1999, 30, 1417.
66. Squire, I.B.; Lees, K.R.; Pryse-Phillips, W.; Kertesz, A.; Bamford, J. Ann. N. Y. Acad. Sci., 1995, 765, 317.
67. Muir, K.W.; Holzapfel, L.; Lees, K.R. Cerebrovasc. Dis., 2000, 10, 431.
68. Diener, H.C.; Cortens, M.; Ford, G.; Grotta, J.; Hacke, W.; Kaste, M.; Koudstaal, P.J.; Wessel, T. Stroke, 2000, 31, 2543.
69. Enlimomab Acute Stroke Trial Investigators. Neurology, 2001, 57, 1428.
70. The Safety Study of Tirilazad Mesylate in Patients with Acute Ischemic Stroke (STIPAS) Investigators. Stroke, 1994, 25, 418.
71. The Randomized Trial of Tirilazad Mesylate in Patients with Acute Stroke (RANTTAS) Investigators. Stroke, 1996, 27, 1453.
72. Johnston, K.C.; Li, J.Y.; Lyden, P.D.; Hanson, S.K.; Feasby, T.E.; Adams, R.J.; Faught, R.E.; Haley, E.C. Stroke, 1998, 29, 447.
73. Clark, W.M.; Wechsler, L.R.; Sabounjian, L.A.; Schwiderski, U.E. Neurology, 2001, 57, 1595.
74. Dávalos, A.; Castillo, J.; Alvarez-Sabin. J.; Secades, J.J.; Mercadal, J.; López, S.; Cobo, E.; Warach, S.; Sherman, D.; Clark, W.M.; Lozano, R.; Stroke, 2002, 33, 2850.